查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1675588

2025 年至 2033 年经导管主动脉瓣植入市场（依手术程序、最终使用者和地区划分）

Transcatheter Aortic Valve Implantation Market by Procedure, End User, and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 145 Pages | 商品交期: 2-3个工作天内

价格

2024 年全球经导管主动脉瓣植入 (TAVI) 市场规模达到 70 亿美元。 展望未来， IMARC Group预计到 2033 年市场规模将达到 174 亿美元，2025-2033 年期间的成长率 (CAGR) 为 10.12%。冠状动脉疾病盛行率的不断上升、微创疗法的日益普及以及老年人口的不断增加是推动市场发展的一些关键因素。

经导管主动脉瓣植入术 (TAVI) 是一种微创手术，用于治疗主动脉瓣狭窄，主动脉瓣狭窄是一种心臟疾病，导致从心臟到身体其他部位的血流减少。在手术过程中，会在患者的腹股沟或胸部做一个小切口。插入导管并经由股动脉或主动脉引导至狭窄的主动脉瓣。由生物材料（例如动物组织或合成材料）製成的人工瓣膜通过导管部署并放置在狭窄的瓣膜内，该瓣膜扩张以取代旧瓣膜，使血液从心臟自由流出。 TAVI 可在局部麻醉下进行。与传统手术相比，此手术恢復时间较短，且併发症风险较低，且可用于病情过于严重或虚弱而无法接受开胸心臟手术的患者。

经导管主动脉瓣植入术 (TAVI) 市场趋势：

患有心臟衰竭、高血压、冠状动脉疾病和心血管疾病 (CVD)，尤其是主动脉瓣狭窄的患者数量不断增加，这主要推动了经导管主动脉瓣植入 (TAVI) 市场的成长。除此之外，由于微创手术 (MIS) 具有住院时间缩短、恢復时间缩短、疗效更佳、整体医疗支出更低等优势，相较于传统开胸心臟手术，消费者对此的偏好正在转变，这为市场创造了积极的前景。此外，消费者对主动脉瓣疾病和可用治疗方案的认识不断提升，从而实现早期诊断和及时治疗，这也促进了市场的成长。除此之外，对研发 (R&D) 计画的大量资金投入和 TAVI 程序的持续技术进步（例如生物瓣膜、自膨瓣膜和其他创新设备的开发）正在加强市场的成长。此外，医疗保健行业的强劲增长、临床试验数量的增加、持续的产品创新、老年人口的增加以及优惠的报销政策为市场带来了丰厚的成长机会。

本报告解答的关键问题

  • 全球经导管主动脉瓣植入术（TAVI）市场有多大？ 2025 年至 2033 年期间全球经导管主动脉瓣植入 (TAVI) 市场的预期成长率为何？
  • 推动全球经导管主动脉瓣植入（TAVI）市场发展的关键因素有哪些？
  • COVID-19 对全球经导管主动脉瓣植入 (TAVI) 市场有何影响？
  • 根据手术程序，全球经导管主动脉瓣植入术 (TAVI) 市场如何分布？
  • 根据最终用户，全球经导管主动脉瓣植入 (TAVI) 市场分布如何？
  • 全球经导管主动脉瓣植入术（TAVI）市场的主要区域有哪些？
  • 全球经导管主动脉瓣植入术 (TAVI) 市场的关键参与者/公司有哪些？

目录

第 1 章：前言

第 2 章：范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 次要来源
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球经导管主动脉瓣植入 (TAVI) 市场

  • 市场概况
  • 市场表现
  • COVID-19 的影响
  • 市场预测

第 6 章：市场区隔：依程序

  • 经股动脉手术
  • 经心尖植入
  • 经主动脉植入

第 7 章：市场区隔：按最终用户

  • 医院
  • 诊断实验室
  • 门诊手术中心
  • 诊所
  • 其他的

第 8 章：市场区隔：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场区隔：依国家

第九章：驱动因素、限制因素与机会

  • 概述
  • 驱动程式
  • 限制
  • 机会

第 10 章：价值链分析

第 11 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 12 章：价格分析

第 13 章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Abbott Laboratories
    • Boston Scientific Corporation
    • Edwards Lifesciences Corporation
    • JC Medical Inc. (Genesis Medtech International Private Limited)
    • Medtronic plc
    • Meril Life Sciences Pvt. Ltd.
    • NVT AG (Biosensors International Group)
    • Venus Medtech (Hangzhou) Inc.
Product Code: SR112025A7501

The global transcatheter aortic valve implantation (TAVI) market size reached USD 7.0 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 17.4 Billion by 2033, exhibiting a growth rate (CAGR) of 10.12% during 2025-2033. The increasing prevalence of coronary artery disease, the rising adoption of minimally invasive therapies, and the expanding geriatric population represent some of the key factors driving the market.

Transcatheter Aortic Valve Implantation (TAVI) refers to a minimally invasive surgical procedure used to treat aortic stenosis, a heart condition in which the aortic valve narrows, resulting in reduced blood flow from the heart to the rest of the body. During the procedure, a small incision is made in the patient's groin or chest. A catheter is inserted and guided through the femoral artery or the aorta to the narrowed aortic valve. An artificial valve made of biological material, such as animal tissue or synthetic materials, is deployed through the catheter and positioned inside the narrowed valve, which expands to replace the old valve, allowing blood to flow freely from the heart. TAVI can be performed under local anesthesia. Compared to traditional surgery, it has a shorter recovery time and a lower risk of complications and can be performed on patients who are too ill or frail to undergo open-heart surgery.

Transcatheter Aortic Valve Implantation (TAVI) Market Trends:

The growing number of patients suffering from heart failure, hypertension, coronary artery disease, and cardiovascular diseases (CVDs), particularly aortic stenosis, is primarily driving the transcatheter aortic valve implantation (TAVI) market growth. Besides this, the shifting consumer preference for minimally invasive surgery (MIS) over conventional open-heart surgery due to its advantages, such as reduced hospital stay, shorter recovery time, improved outcomes, and lower overall healthcare spending, is creating a positive outlook for the market. Moreover, the escalating consumer awareness about aortic valve disease and available treatment options leading to early diagnosis and timely treatment is contributing to the market growth. In addition to this, the extensive funding in research and development (R&D) initiatives and ongoing technological advancements in the TAVI procedure, such as the development of bioprosthetic valves, self-expanding valves, and other innovative devices, are strengthening the market growth. Furthermore, the bolstering growth of the healthcare industry, the increasing number of clinical trials, continuous product innovations, the expanding geriatric population, and favorable reimbursement policies are presenting remunerative growth opportunities for the market.

Key Market Segmentation:

Procedure Insights:

  • Transfemoral Procedure
  • Transapical Implantation
  • Transaortic Implantation

End User Insights:

  • Hospitals
  • Diagnostic Labs
  • Ambulatory Surgical Centers
  • Clinics
  • Others

Regional Insights:

  • North America
  • United States
  • Canada
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa
  • The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for transcatheter aortic valve implantation (TAVI). Some of the factors driving the North America transcatheter aortic valve implantation (TAVI) market included the expanding prevalence of cardiovascular diseases, the rising adoption of minimally invasive therapies, and ongoing technological advancements.

Competitive Landscape:

  • The report has also provided a comprehensive analysis of the competitive landscape in the global transcatheter aortic valve implantation (TAVI) market. Detailed profiles of all major companies have also been provided. Some of the companies covered include Abbott Laboratories, Boston Scientific Corporation, Edwards Lifesciences Corporation, JC Medical Inc. (Genesis Medtech International Private Limited), Medtronic plc, Meril Life Sciences Pvt. Ltd., NVT AG (Biosensors International Group), Venus Medtech (Hangzhou) Inc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report

  • 1.How big is the global Transcatheter Aortic Valve Implantation (TAVI) market?
  • 2.What is the expected growth rate of the global Transcatheter Aortic Valve Implantation (TAVI) market during 2025-2033?
  • 3.What are the key factors driving the global Transcatheter Aortic Valve Implantation (TAVI) market?
  • 4.What has been the impact of COVID-19 on the global Transcatheter Aortic Valve Implantation (TAVI) market?
  • 5.What is the breakup of the global Transcatheter Aortic Valve Implantation (TAVI) market based on the procedure?
  • 6.What is the breakup of the global Transcatheter Aortic Valve Implantation (TAVI) market based on the end user?
  • 7.What are the key regions in the global Transcatheter Aortic Valve Implantation (TAVI) market?
  • 8.Who are the key players/companies in the global Transcatheter Aortic Valve Implantation (TAVI) market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Transcatheter Aortic Valve Implantation (TAVI) Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Procedure

  • 6.1 Transfemoral Procedure
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Transapical Implantation
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Transaortic Implantation
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by End User

  • 7.1 Hospitals
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Diagnostic Labs
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Ambulatory Surgical Centers
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Clinics
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia-Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 Drivers, Restraints, and Opportunities

  • 9.1 Overview
  • 9.2 Drivers
  • 9.3 Restraints
  • 9.4 Opportunities

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 Abbott Laboratories
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
      • 13.3.1.4 SWOT Analysis
    • 13.3.2 Boston Scientific Corporation
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
      • 13.3.2.3 Financials
      • 13.3.2.4 SWOT Analysis
    • 13.3.3 Edwards Lifesciences Corporation
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
      • 13.3.3.3 Financials
      • 13.3.3.4 SWOT Analysis
    • 13.3.4 JC Medical Inc. (Genesis Medtech International Private Limited)
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
    • 13.3.5 Medtronic plc
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
      • 13.3.5.3 Financials
      • 13.3.5.4 SWOT Analysis
    • 13.3.6 Meril Life Sciences Pvt. Ltd.
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
    • 13.3.7 NVT AG (Biosensors International Group)
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
    • 13.3.8 Venus Medtech (Hangzhou) Inc.
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
      • 13.3.8.3 Financials

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

List of Figures

  • Figure 1: Global: Transcatheter Aortic Valve Implantation Market: Major Drivers and Challenges
  • Figure 2: Global: Transcatheter Aortic Valve Implantation Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Transcatheter Aortic Valve Implantation Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Transcatheter Aortic Valve Implantation Market: Breakup by Procedure (in %), 2024
  • Figure 5: Global: Transcatheter Aortic Valve Implantation Market: Breakup by End User (in %), 2024
  • Figure 6: Global: Transcatheter Aortic Valve Implantation Market: Breakup by Region (in %), 2024
  • Figure 7: Global: Transcatheter Aortic Valve Implantation (Transfemoral Procedure) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 8: Global: Transcatheter Aortic Valve Implantation (Transfemoral Procedure) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 9: Global: Transcatheter Aortic Valve Implantation (Transapical Implantation) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 10: Global: Transcatheter Aortic Valve Implantation (Transapical Implantation) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 11: Global: Transcatheter Aortic Valve Implantation (Transaortic Implantation) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 12: Global: Transcatheter Aortic Valve Implantation (Transaortic Implantation) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: Transcatheter Aortic Valve Implantation (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 14: Global: Transcatheter Aortic Valve Implantation (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 15: Global: Transcatheter Aortic Valve Implantation (Diagnostic Labs) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 16: Global: Transcatheter Aortic Valve Implantation (Diagnostic Labs) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 17: Global: Transcatheter Aortic Valve Implantation (Ambulatory Surgical Centers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 18: Global: Transcatheter Aortic Valve Implantation (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 19: Global: Transcatheter Aortic Valve Implantation (Clinics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 20: Global: Transcatheter Aortic Valve Implantation (Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 21: Global: Transcatheter Aortic Valve Implantation (Other End Users) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 22: Global: Transcatheter Aortic Valve Implantation (Other End Users) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 23: North America: Transcatheter Aortic Valve Implantation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 24: North America: Transcatheter Aortic Valve Implantation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 25: United States: Transcatheter Aortic Valve Implantation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 26: United States: Transcatheter Aortic Valve Implantation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 27: Canada: Transcatheter Aortic Valve Implantation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 28: Canada: Transcatheter Aortic Valve Implantation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 29: Asia-Pacific: Transcatheter Aortic Valve Implantation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 30: Asia-Pacific: Transcatheter Aortic Valve Implantation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 31: China: Transcatheter Aortic Valve Implantation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 32: China: Transcatheter Aortic Valve Implantation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 33: Japan: Transcatheter Aortic Valve Implantation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 34: Japan: Transcatheter Aortic Valve Implantation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 35: India: Transcatheter Aortic Valve Implantation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 36: India: Transcatheter Aortic Valve Implantation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 37: South Korea: Transcatheter Aortic Valve Implantation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 38: South Korea: Transcatheter Aortic Valve Implantation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 39: Australia: Transcatheter Aortic Valve Implantation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 40: Australia: Transcatheter Aortic Valve Implantation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 41: Indonesia: Transcatheter Aortic Valve Implantation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 42: Indonesia: Transcatheter Aortic Valve Implantation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 43: Others: Transcatheter Aortic Valve Implantation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 44: Others: Transcatheter Aortic Valve Implantation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 45: Europe: Transcatheter Aortic Valve Implantation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 46: Europe: Transcatheter Aortic Valve Implantation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 47: Germany: Transcatheter Aortic Valve Implantation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 48: Germany: Transcatheter Aortic Valve Implantation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 49: France: Transcatheter Aortic Valve Implantation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 50: France: Transcatheter Aortic Valve Implantation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 51: United Kingdom: Transcatheter Aortic Valve Implantation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 52: United Kingdom: Transcatheter Aortic Valve Implantation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 53: Italy: Transcatheter Aortic Valve Implantation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 54: Italy: Transcatheter Aortic Valve Implantation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 55: Spain: Transcatheter Aortic Valve Implantation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 56: Spain: Transcatheter Aortic Valve Implantation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 57: Russia: Transcatheter Aortic Valve Implantation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 58: Russia: Transcatheter Aortic Valve Implantation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 59: Others: Transcatheter Aortic Valve Implantation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 60: Others: Transcatheter Aortic Valve Implantation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 61: Latin America: Transcatheter Aortic Valve Implantation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 62: Latin America: Transcatheter Aortic Valve Implantation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 63: Brazil: Transcatheter Aortic Valve Implantation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 64: Brazil: Transcatheter Aortic Valve Implantation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 65: Mexico: Transcatheter Aortic Valve Implantation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 66: Mexico: Transcatheter Aortic Valve Implantation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 67: Others: Transcatheter Aortic Valve Implantation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 68: Others: Transcatheter Aortic Valve Implantation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 69: Middle East and Africa: Transcatheter Aortic Valve Implantation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 70: Middle East and Africa: Transcatheter Aortic Valve Implantation Market: Breakup by Country (in %), 2024
  • Figure 71: Middle East and Africa: Transcatheter Aortic Valve Implantation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Global: Transcatheter Aortic Valve Implantation Industry: Drivers, Restraints, and Opportunities
  • Figure 73: Global: Transcatheter Aortic Valve Implantation Industry: Value Chain Analysis
  • Figure 74: Global: Transcatheter Aortic Valve Implantation Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Transcatheter Aortic Valve Implantation Market: Key Industry Highlights, 2024 & 2033
  • Table 2: Global: Transcatheter Aortic Valve Implantation Market Forecast: Breakup by Procedure (in Million USD), 2025-2033
  • Table 3: Global: Transcatheter Aortic Valve Implantation Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 4: Global: Transcatheter Aortic Valve Implantation Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 5: Global: Transcatheter Aortic Valve Implantation Market: Competitive Structure
  • Table 6: Global: Transcatheter Aortic Valve Implantation Market: Key Players